Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seungwon Kim

Showing results (111-120 of 148) with videos related to

Pageof 15
Sort By:
Head & Neck|January 12, 2022
Poor treatment tolerance in head and neck cancer patients with low muscle massMarco A Mascarella, Terral Patel, Varun Vendra, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|June 29, 2026
Preoperative Neutrophil-to-Lymphocyte Ratio Predicts Recurrence in HPV-Associated Oropharyngeal Cancer After Transoral Robotic SurgeryMicah K Harris, Kelly Daniels, Vanessa Helou, et al.
Cancers|June 18, 2020
Phase I Study of Ficlatuzumab and Cetuximab in Cetuximab-Resistant, Recurrent/Metastatic Head and Neck CancerJulie E Bauman, James Ohr, William E Gooding, et al.
International Journal of Radiation Oncology, Biology, Physics|June 16, 2016
Risk of Severe Toxicity According to Site of Recurrence in Patients Treated With Stereotactic Body Radiation Therapy for Recurrent Head and Neck CancerDiane C Ling, John A Vargo, Robert L Ferris, et al.
Annals of Surgical Oncology|November 1, 2025
Facial Vein Ligation is Associated with Lymphedema Among Patients with Head and Neck Cancer Undergoing Surgery and RadiationRichard A Raad, Fendi Obuekwe, Joshua D Smith, et al.
Health & Place|May 21, 2021
Individual, household and neighborhood risk factors for malaria in the Democratic Republic of the Congo support new approaches to programmatic interventionMargaret Carrel, Seungwon Kim, Melchior Kashamuka Mwandagalirwa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2017
Phase Ib Study of Immune Biomarker Modulation with Neoadjuvant Cetuximab and TLR8 Stimulation in Head and Neck Cancer to Overcome Suppressive Myeloid SignalsGulidanna Shayan, Benjamin A Kansy, Sandra P Gibson, et al.
JCO Precision Oncology|November 20, 2024
CD8<sup>+</sup> Tumor-Infiltrating Lymphocytes in Head and Neck Cancer: A ReviewKevin J Contrera, Matthew E Spector, Liron Pantanowitz, et al.
Oral Oncology|March 29, 2026
Predicting treatment intolerance in operable head and neck cancer using the modified head and neck surgery risk indexMarco A Mascarella, Alex Mlynarek, Keith Richardson, et al.
Oral Oncology|October 29, 2021
Surgical factors associated with patient-reported quality of life outcomes after free flap reconstruction of the oral cavityJoaquin E Jimenez, Marci Lee Nilsen, William E Gooding, et al.
Pageof 15

Showing results (111-120 of 148) with videos related to

Sort By:
Pageof 15
Head & Neck|January 12, 2022
Poor treatment tolerance in head and neck cancer patients with low muscle massMarco A Mascarella, Terral Patel, Varun Vendra, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|June 29, 2026
Preoperative Neutrophil-to-Lymphocyte Ratio Predicts Recurrence in HPV-Associated Oropharyngeal Cancer After Transoral Robotic SurgeryMicah K Harris, Kelly Daniels, Vanessa Helou, et al.
Cancers|June 18, 2020
Phase I Study of Ficlatuzumab and Cetuximab in Cetuximab-Resistant, Recurrent/Metastatic Head and Neck CancerJulie E Bauman, James Ohr, William E Gooding, et al.
International Journal of Radiation Oncology, Biology, Physics|June 16, 2016
Risk of Severe Toxicity According to Site of Recurrence in Patients Treated With Stereotactic Body Radiation Therapy for Recurrent Head and Neck CancerDiane C Ling, John A Vargo, Robert L Ferris, et al.
Annals of Surgical Oncology|November 1, 2025
Facial Vein Ligation is Associated with Lymphedema Among Patients with Head and Neck Cancer Undergoing Surgery and RadiationRichard A Raad, Fendi Obuekwe, Joshua D Smith, et al.
Health & Place|May 21, 2021
Individual, household and neighborhood risk factors for malaria in the Democratic Republic of the Congo support new approaches to programmatic interventionMargaret Carrel, Seungwon Kim, Melchior Kashamuka Mwandagalirwa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 25, 2017
Phase Ib Study of Immune Biomarker Modulation with Neoadjuvant Cetuximab and TLR8 Stimulation in Head and Neck Cancer to Overcome Suppressive Myeloid SignalsGulidanna Shayan, Benjamin A Kansy, Sandra P Gibson, et al.
JCO Precision Oncology|November 20, 2024
CD8<sup>+</sup> Tumor-Infiltrating Lymphocytes in Head and Neck Cancer: A ReviewKevin J Contrera, Matthew E Spector, Liron Pantanowitz, et al.
Oral Oncology|March 29, 2026
Predicting treatment intolerance in operable head and neck cancer using the modified head and neck surgery risk indexMarco A Mascarella, Alex Mlynarek, Keith Richardson, et al.
Oral Oncology|October 29, 2021
Surgical factors associated with patient-reported quality of life outcomes after free flap reconstruction of the oral cavityJoaquin E Jimenez, Marci Lee Nilsen, William E Gooding, et al.
Pageof 15